These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 8556970

  • 1. Carbamazepine and cocaine-cue reactivity.
    Hersh D, Bauer LO, Kranzler HR.
    Drug Alcohol Depend; 1995 Oct; 39(3):213-21. PubMed ID: 8556970
    [Abstract] [Full Text] [Related]

  • 2. Electroencephalographic activity and mood in cocaine-dependent outpatients: effects of cocaine cue exposure.
    Bauer LO, Kranzler HR.
    Biol Psychiatry; 1994 Aug 01; 36(3):189-97. PubMed ID: 7948456
    [Abstract] [Full Text] [Related]

  • 3. Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride.
    Robbins SJ, Ehrman RN, Childress AR, O'Brien CP.
    Addict Behav; 1992 Aug 01; 17(5):491-9. PubMed ID: 1332435
    [Abstract] [Full Text] [Related]

  • 4. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.
    Halikas JA, Crosby RD, Pearson VL, Graves NM.
    Clin Pharmacol Ther; 1997 Jul 01; 62(1):89-105. PubMed ID: 9246023
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues.
    Harris DS, Batki SL, Berger SP.
    Am J Drug Alcohol Abuse; 2004 Nov 01; 30(4):765-82. PubMed ID: 15624548
    [Abstract] [Full Text] [Related]

  • 6. Dissociation between subjective and behavioral responses after cocaine stimuli presentations.
    Dudish-Poulsen SA, Hatsukami DK.
    Drug Alcohol Depend; 1997 Jul 25; 47(1):1-9. PubMed ID: 9279492
    [Abstract] [Full Text] [Related]

  • 7. Cue-evoked arousal in cocaine users: a study of variance and predictive value.
    Negrete JC, Emil S.
    Drug Alcohol Depend; 1992 Jun 25; 30(2):187-92. PubMed ID: 1321711
    [Abstract] [Full Text] [Related]

  • 8. Quantitative electroencephalographic differences associated with alcohol, cocaine, heroin and dual-substance dependence.
    Costa L, Bauer L.
    Drug Alcohol Depend; 1997 Jun 06; 46(1-2):87-93. PubMed ID: 9246556
    [Abstract] [Full Text] [Related]

  • 9. Quantitative electroencephalographic analyses in cocaine-preferring polysubstance abusers during abstinence.
    Roemer RA, Cornwell A, Dewart D, Jackson P, Ercegovac DV.
    Psychiatry Res; 1995 Oct 16; 58(3):247-57. PubMed ID: 8570780
    [Abstract] [Full Text] [Related]

  • 10. Effects of cocaine on P3B in cocaine abusers.
    Herning RI, Glover BJ, Guo X.
    Neuropsychobiology; 1994 Oct 16; 30(2-3):132-42. PubMed ID: 7800160
    [Abstract] [Full Text] [Related]

  • 11. Differences between responders and nonresponders to cocaine cues in the laboratory.
    Avants SK, Margolin A, Kosten TR, Cooney NL.
    Addict Behav; 1995 Oct 16; 20(2):215-24. PubMed ID: 7484315
    [Abstract] [Full Text] [Related]

  • 12. Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design.
    Halikas JA, Crosby RD, Carlson GA, Crea F, Graves NM, Bowers LD.
    Clin Pharmacol Ther; 1991 Jul 16; 50(1):81-95. PubMed ID: 1855356
    [Abstract] [Full Text] [Related]

  • 13. Carbamazepine treatment of cocaine dependence: a placebo-controlled trial.
    Kranzler HR, Bauer LO, Hersh D, Klinghoffer V.
    Drug Alcohol Depend; 1995 Jun 16; 38(3):203-11. PubMed ID: 7555620
    [Abstract] [Full Text] [Related]

  • 14. Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study.
    Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR.
    Am J Drug Alcohol Abuse; 1993 Jun 16; 19(4):451-64. PubMed ID: 8273766
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of a cue exposure paradigm for the evaluation of a potential pharmacotherapeutic agents for cocaine dependence.
    Kranzler HR, Bauer LO.
    Addict Behav; 1993 Jun 16; 18(6):599-60. PubMed ID: 8178699
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of benzodiazepine withdrawal symptoms with carbamazepine.
    Garcia-Borreguero D, Bronisch T, Apelt S, Yassouridis A, Emrich HM.
    Eur Arch Psychiatry Clin Neurosci; 1991 Jun 16; 241(3):145-50. PubMed ID: 1686406
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.